Central Pharmaceutical JSC No2 (HSTC:DP2) Receivables Turnover: 0.00 (As of . 20)


HSTC:DP2 Central Pharmaceutical JSC No2 HSTC:DP2
23 GF Score
Price ₫4,900.00
View Full Analysis

What is Central Pharmaceutical JSC No2 Receivables Turnover?

Central Pharmaceutical JSC No2 HSTC:DP2 23 Receivables Turnover is 0.00 as of . 20. GuruFocus rates HSTC:DP2 with a GF Score™ of 23/100.

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Central Pharmaceutical JSC No2's Revenue for the six months ended in . 20 was ₫0.00 Mil. Central Pharmaceutical JSC No2's average Accounts Receivable for the six months ended in . 20 was ₫0.00 Mil.

Central Pharmaceutical JSC No2  (HSTC:DP2) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.

Central Pharmaceutical JSC No2 Receivables Turnover Related Terms

Central Pharmaceutical JSC No2 Receivables Turnover Historical Data

* Premium members only.

The historical data trend for Central Pharmaceutical JSC No2's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Central Pharmaceutical JSC No2 Receivables Turnover Chart

Central Pharmaceutical JSC No2 Annual Data
Trend
Receivables Turnover

Central Pharmaceutical JSC No2 Semi-Annual Data
Receivables Turnover

HSTC:DP2 vs : Receivables Turnover Comparison

For the Pharmaceutical Retailers subindustry, Central Pharmaceutical JSC No2's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Central Pharmaceutical JSC No2 Receivables Turnover vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Central Pharmaceutical JSC No2's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Central Pharmaceutical JSC No2's Receivables Turnover falls into.


HSTC:DP2
23GF Score
Central Pharmaceutical JSC No2 HSTC:DP2
Receivables Turnover is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Central Pharmaceutical JSC No2 Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Central Pharmaceutical JSC No2's Receivables Turnover for the fiscal year that ended in . 20 is calculated as

Receivables Turnover (A: . 20 )
=Revenue / Average Accounts Receivable
=Revenue (A: . 20 ) / ((Accounts Receivable (A: . 20 ) + Accounts Receivable (A: . 20 )) / count )
= / (( + ) / 1 )
= / 0
=N/A

Central Pharmaceutical JSC No2's Receivables Turnover for the quarter that ended in . 20 is calculated as

Receivables Turnover (Q: . 20 )
=Revenue / Average Accounts Receivable
=Revenue (Q: . 20 ) / ((Accounts Receivable (Q: . 20 ) + Accounts Receivable (Q: . 20 )) / count )
= / (( + ) / 1 )
= / 0
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Receivables Turnover →
What does a Receivables Turnover of 0.00 mean?
Central Pharmaceutical JSC No2 (HSTC:DP2) has a Receivables Turnover of 0.00 as of . 20. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Central Pharmaceutical JSC No2 and its competitors.
Is Central Pharmaceutical JSC No2's Receivables Turnover too high?
Central Pharmaceutical JSC No2's current Receivables Turnover is 0.00. Overall, Central Pharmaceutical JSC No2 has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Central Pharmaceutical JSC No2's Receivables Turnover compare to ?
Central Pharmaceutical JSC No2's Receivables Turnover of 0.00 can be compared against companies in the Healthcare Providers & Services industry. The industry median Receivables Turnover is 7.70. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Healthcare Providers & Services company?
The median Receivables Turnover among Healthcare Providers & Services companies is 7.70, based on 655 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Central Pharmaceutical JSC No2 and its competitors. For the Healthcare Providers & Services industry, the median Receivables Turnover is 7.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Central Pharmaceutical JSC No2's current Receivables Turnover is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Central Pharmaceutical JSC No2 stock overvalued right now?
Central Pharmaceutical JSC No2 (HSTC:DP2) has a current Receivables Turnover of 0.00. The current Receivables Turnover is 0.00. Central Pharmaceutical JSC No2's overall GF Score™ is 23/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Central Pharmaceutical JSC No2 (HSTC:DP2), the current Receivables Turnover is 0.00 as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Central Pharmaceutical JSC No2 Business Description

Comparable Companies
Address No. 9 Tran Thanh Tong, Bach Dang Ward, Hai Ba Trung District, Hanoi, VNM
Central Pharmaceutical JSC No2 is engaged in the Trading of medicinal materials, pharmaceutical materials, chemicals, essential oils, modern medicines, traditional medicine drugs, cosmetics, and nutritious foods. Some of its products include Gentamycin injection solution 80; Genatreson Skin Cream; Ferimax Hard Capsules and others.
23GF Score

Get the complete analysis for HSTC:DP2

Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₫4,900.00
Price